Keen-Hun Tai

Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial

Paul Keall, Doan Trang Nguyen, Ricky O'Brien, Emily Hewson, Helen Ball, Per Poulsen, Jeremy Booth, Peter Greer, Perry Hunter, Lee Wilton, Regina Bromley, John Kipritidis, Thomas Eade, Andrew Kneebone, George Hruby, Trevor Moodie, Amy Hayden, Sandra Turner, Sankar Arumugam, Mark Sidhom, et al.

Journal article  |  2020  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE: Kilovoltage intrafraction monitoring (KIM) is a novel software platform implemented on standard radiation therapy systems..

Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial

Emily A Hewson, Doan T Nguyen, Ricky O'Brien, Per R Poulsen, Jeremy T Booth, Peter Greer, Thomas Eade, Andrew Kneebone, George Hruby, Trevor Moodie, Amy J Hayden, Sandra L Turner, Nicholas Hardcastle, Shankar Siva, Keen Hun Tai, Jarad Martin, Paul J Keall

Journal article  |  2020  |  RADIOTHERAPY AND ONCOLOGY

PURPOSE: Stereotactic Ablative Radiotherapy (SABR) has recently emerged as a favourable treatment option for prostate cancer patie..

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

David Joseph, James W Denham, Allison Steigler, David S Lamb, Nigel A Spry, John Stanley, Tom Shannon, Gillian Duchesne, Chris Atkinson, John HL Matthews, Sandra Turner, Lizbeth Kenny, David Christie, Keen-Hun Tai, Nirdosh Kumar Gogna, Rachel Kearvell, Judy Murray, Martin A Ebert, Annette Haworth, Brett Delahunt, et al.

Journal article  |  2020  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE: To clarify the relative effects of duration of androgen suppression (AS) and radiation dose escalation (RDE) on distant p..

The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial

Emily A Hewson, Doan Trang Nguyen, Ricky O'Brien, Jung-Ha Kim, Tim Montanaro, Trevor Moodie, Peter B Greer, Nicholas Hardcastle, Thomas Eade, Andrew Kneebone, George Hruby, Amy J Hayden, Sandra Turner, Shankar Siva, Keen-Hun Tai, Perry Hunter, Joshua Sams, Per Rugaard Poulsen, Jeremy T Booth, Jarad Martin, et al.

Journal article  |  2019  |  MEDICAL PHYSICS

PURPOSE: Kilovoltage intrafraction monitoring (KIM) allows for real-time image guidance for tracking tumor motion in six-degrees-o..

TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol

Jarad Martin, Paul Keall, Shankar Siva, Peter Greer, David Christie, Kevin Moore, Jason Dowling, David Pryor, Peter Chong, Nicholas McLeod, Avi Raman, James Lynam, Joanne Smart, Christopher Oldmeadow, Colin I Tang, Declan G Murphy, Jeremy Millar, Keen Hun Tai, Lois Holloway, Penny Reeves, et al.

Journal article  |  2019  |  BMJ OPEN

INTRODUCTION: Stereotactic body radiotherapy (SBRT) is a non-invasive alternative to surgery for the treatment of non-metastatic p..

Is MLC Tracking Or Gating a Better Real-Time Correction Strategy? An Analysis of the TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) Trial

E Hewson, D Nguyen, R O'Brien, P Poulsen, J Booth, P Greer, T Eade, A Kneebone, G Hruby, T Moodie, A Hayden, S Turner, N Hardcastle, S Siva, K Tai, J Martin, P Keall

Conference Proceedings  |  2019  |  MEDICAL PHYSICS

Real-Time tracking improves treatment: The TROG Stereo Prostate Ablative Radiotherapy with KIM trial

P Keall, DT Nguyen, R O'Brien, E Hewson, H Ball, P Poulsen, J Booth, P Greer, P Hunter, L Wilton, R Bromley, J Kipritidis, T Eade, A Kneebone, G Hruby, T Moodie, A Hayden, S Turner, S Arumugam, M Sidhom, et al.

Conference Proceedings  |  2019  |  RADIOTHERAPY AND ONCOLOGY

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

James W Denham, David Joseph, David S Lamb, Nigel A Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen-Hun Tai, David Christie, Lizbeth Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Chris Oldmeadow, John Attia, Allison Steigler

Journal article  |  2019  |  LANCET ONCOLOGY

BACKGROUND: The optimal duration of androgen suppression for men with locally advanced prostate cancer receiving radiotherapy with..

Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials

DA Loblaw, J Bassett, C D'Este, G Pond, P Cheung, M Frydenberg, MT King, H Lukka, S Malone, JL Millar, RL Milne, T Pickles, R Smith, MR Stockler, S Turner, KH Tai, H Woo, G Duchesne

Conference Proceedings  |  2018  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial

Shankar Siva, Mathias Bressel, Declan G Murphy, Mark Shaw, Sarat Chander, John Violet, Keen Hun Tai, Cristian Udovicich, Andrew Lim, Lisa Selbie, Michael S Hofman, Tomas Kron, Daniel Moon, Jeremy Goad, Nathan Lawrentschuk, Farshad Foroudi

Journal article  |  2018  |  EUROPEAN UROLOGY

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is an emerging treatment option for oligometastatic prostate cancer. Ho..